Dihydropyridine Calcium Antagonists Increase Fibrinolytic Activity: A Systematic Review
- 27 December 2006
- journal article
- review article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 27 (7), 1293-1308
- https://doi.org/10.1038/sj.jcbfm.9600431
Abstract
Calcium antagonists have been shown to be superior over other antihypertensive drugs to prevent stroke. Because this cannot be fully attributed to blood pressure lowering effects, other mechanisms seem to play a role. Previously we found in patients with subarachnoid hemorrhage that nimodipine enhances fibrinolytic activity. The purpose of this systematic review was to investigate the fibrinolytic effect of calcium antagonists in general, especially in patients with hypertension. We systematically studied the entire PUBMED and EMBASE database with the search terms ‘calcium antagonist’ combined with ‘fibrinolysis’, ‘(euglobulin) clot lysis time’ (ECLT), ‘tissue plasminogen activator’ (tPA), or ‘plasminogen activator inhibitor’ (PAI). Twenty-six prospective studies were identified and 22 manuscripts were included (802 investigated individuals). The results show that calcium antagonists significantly increase fibrinolysis as shown by a reduction of the ECLT standardized mean differences (SMD) −0.58 (95% confidence interval (CI) −1.05 to −0.11)) and an increase of tPA activity (SMD 0.73 (95% CI 0.25 to 1.21)). This increase of fibrinolysis is apparently caused by an increase of the tPA antigen level (SMD 0.16 (95% CI −0.05 to 0.37)) and a decrease of the plasminogen activator inhibitor-1 antigen antigen (SMD −0.36 (95% CI −0.74 to 0.02)). A sensitivity analysis showed that dihydropyridines, but not phenylalkylamines, exert a fibrinolytic effect. This fibrinolytic effect is not only seen in patients with subarachnoid hemorrhage but also in hypertensive patients. In conclusions, calcium antagonists increase fibrinolytic activity. This may add to the beneficial pharmacological effect of calcium antagonists to prevent ischemic events in patients with hypertension and subarachnoid hemorrhage.Keywords
This publication has 47 references indexed in Scilit:
- Platelets synthesize large amounts of active plasminogen activator inhibitor 1Blood, 2004
- Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trialClinical Therapeutics, 2004
- Association between obesity and a prothrombotic state: the Framingham Offspring StudyThrombosis and Haemostasis, 2004
- Effect on Cerebral Vasospasm of Coil Embolization Followed by Microcatheter Intrathecal Urokinase Infusion Into the Cisterna MagnaStroke, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Fosinopril Versus Amlodipine Comparative Treatments StudyCirculation, 2002
- Randomized Double-Blind Comparison of a Calcium Antagonist and a Diuretic in Elderly HypertensivesHypertension, 1999
- Hemorrhagic potential of combined diltiazem and recombinant tissue-type plasminogen activator administrationAmerican Heart Journal, 1993
- Does Antihypertensive Therapy Affect the Natural Protection Against Thrombosis?Journal of Cardiovascular Pharmacology, 1991
- Differential effects of non-specific beta-blockade and calcium antagonism on blood-clotting mechanismsThe American Journal of Medicine, 1989